Pollen allergy and immunotherapy;Pollenallergien und Immuntherapie

Therapeutische Umschau

Volumn 69, Issue 4, 2012, Pages 239-248

  Schmid Grendelmeier, Peter ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E;

ALLERGEN SPECIFIC IMMUNOTHERAPY; ANAMNESIS; ARTICLE; ASH; BIRCH; CLINICAL EFFECTIVENESS; GRASS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; PATIENT GUIDANCE; POLLEN; POLLEN ALLERGY; SAFETY; SKIN TEST;

ADULT; ALLERGENS; CHILD; DESENSITIZATION, IMMUNOLOGIC; EPITOPES; FOLLOW-UP STUDIES; HUMANS; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SEASONS; TREATMENT OUTCOME;

EID: 84859416316     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930/a000280     Document Type: Article

References (33)

1. Wüthrich B, Schindler C, Leuenberger P, Ackermann-Liebrich U, SAPALDIA-Team. Prevalence of atopy and pollinosis in the adult population of Switzerland. Int Arch Allergy Immunol 1995; 106: 149-56.
2. Braun-Fahrländer C, Wüthrich B, Gassner M, Gritze I, Neu U, Varonier H, et al. Prävalenz und Risikofaktoren einer allergischen Sensibilisierung bei Schulkindern in der Schweiz. Allergologie 1999; 22: 54-64.
3. Imboden M, Nieters A, Bircher AJ, et al. Cytokine gene polymorphisms and atopic disease in two European cohorts. (ECRHS-Basel and SAPALDIA). Clin Mol Allergy 2006; 4: 9.
4. Gerhold K, Avagyan A, Seib C, et al. Prenatal initiation of endotoxin airway exposure prevents subsequent allergen-induced sensitization and airway inflammation in mice. J Allergy Clin Immunol 2006; 118: 666-73.
5. Lauener RP, Birchler T, Adamski J, et al. Expression of CD14 and Tolllike receptor 2 in farmers' and nonfarmers' children. Lancet. 2002; 360: 465-6.
6. Traidl-Hoffmann C, Mariani V, Hochrein H, et al. Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. J Exp Med 2005; 201: 627-36.
7. Downs SH, Schindler C, Liu LJ et al. Reduced exposure to PM10 and attenuated age-related decline in lung function. N Engl J Med. 2007; 357: 2338-47.
8. Szucs TD, Anderhub HP, Rutishauser M. Determinanten der Gesundheitskosten und Versorgungsmuster von Asthma-Patienten in der Schweiz. Schweiz Med Wochenschr 2000; 130: 305-13.
9. Taramarcaz P, Lambelet B, Clot B, Keimer C, Hauser C. Ragweed (Ambrosia) progression and its health risks: will Switzerland resist this invasion? Schweiz Med Wsch 2005; 135: 538-48.
10. Bach S, König V, Clot B, Bircher AJ 2007: Sensitization to ragweed (Ambrosia) pollen in routine patients from the Basle region. European Annals of Allergy and Clinical Immunology 39: 347-9.
11. Gumowski P, Davet A, Clot B, Guibet S, Van-Eck F & Gaudart M. Occurrence of ragweed (Ambrosia artemisiifolia) pollen allergy and sensitization in the Geneva area from 1999 to 2004: the perspective from an allergy outpatient clinic. In: Clot B, Comtois P & Escamilla-Garcia B (ed.), Aerobiolo gical Mono graphs, Volume 1, MeteoSwiss (CH) and University of Montreal (CA), Montreal, Canada, 2011.
12. Davet A, Clot B & Gumowski P, 1 to 3 years delay between sensitization and first symptoms in ragweed allergy. Swiss Medical weekly, Supplementum 2009, 170: 7-8.
13. Ackermann-Liebrich U, Schindler C, Frei P et al. Sensitisation to Ambrosia in Switzerland: a public health threat on the wait. Swiss Med Wkly. 2009; 139: 70-5.
14. Bousquet J, Heinzerling L, Bachert C et al. Practical guide to skin prick tests in allergy to aeroallergens. Allergy. 2011 Nov 4 (Online ahead).
15. Schmid-Grendelmeier P. Rekombinante Allergene: für den Routinegebrauch oder nur zu wissenschaftlichen Zwecken? Hautarzt. 2010; 61: 946-53.
16. Dumitru AF, Shamji M, Wagenmann M et al. Petasol butenoate complex (Ze 339) relieves allergic rhinitis-induced nasal obstruction more effectively than desloratadine. J Allergy Clin Immunol. 2011; 127: 1515-21.
17. Brinkhaus B, Hummelsberger J, Kohnen R et al. Acupuncture and Chinese herbal medicine in the treatment of patients with seasonal allergic rhinitis: a randomized-controlled clinical trial. Allergy. 2004; 59: 953-60.
18. Matricardi PM, Kuna P, Panetta V, Wahn U, Narkus A. Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: a comparison based on meta-analyses. J Allergy Clin Immunol. 2011; 128: 791-799.
19. Ca Calderón MA, Casale TB, Togias A, Bousquet J, Durham SR, Demoly P. Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond. J Allergy Clin Immunol. 2011; 127: 30-8.
20. Durham SR, Walker SM, Varga EM et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med. 1999; 341: 468-75.
21. Matricardi PM, Kuna P, Panetta V, Wahn U, Narkus A. Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: a comparison based on meta-analyses. J Allergy Clin Immunol. 2011; 128: 791-799.
22. Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. Lancet. 2011 Jul 21.
23. Pichler CE, Helbling A, Pichler WJ. Three years of specific immunotherapy with house-dust-mite extracts in patients with rhinitis and asthma: significant improvement of allergen-specific parameters and of nonspecific bronchial hyperreactivity. Allergy. 2001; 56: 301-6.
24. Novak N, Werfel T. Spezifische Immunotherapie und atopische Dermatitis: was ist neu? Hautarzt. 2011; 62: 650-6.
25. Raap U, Wagenmann M, Pfaar O. Allergen-specifische Immuntherapie bei Haustierallerie-ein Update. Hautarzt. 2011; 62: 657-62.
26. Helbling, A. and A. Reimers Immunotherapy in fungal allergy. Curr Allergy Asthma Rep 2002; 3: 447-53.
27. Harder D, Schmid-Grendelmeier P. Spezifische Immuntherapie bei Pollinose: eine praxisbezogene Übersicht. Praxis 2009; 98: 1353-60.
28. Iglesias-Cadarso A, Hernández-Weigand P. Risk factors for systemic reactions to allergen immunotherapy. Curr Opin Allergy Clin Immunol. 2011 Dec; 11: 579-85.
29. Calderón MA, Larenas D, Kleine-Tebbe J et al. European Academy of Allergy and Clinical Immunology task force report on 'dose-response relationship in allergen-specific immunotherapy'. Allergy. 2011; 66: 1345-1359.
30. Radulovic S, Wilson D, Calderon M, Durham S. Systematic reviews of sublingual immunotherapy (SLIT). Allergy. 2011 Jun; 66: 740-52.
31. Wahn U, Tabar A, Kuna P et al. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2009; 123: 160-166.
32. Bufe A, Eberle P, Franke-Beckmann E et al. Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy. J Allergy Clin Immunol. 2009; 123: 167-173.
33. Tay F, Kündig TM, Senti G. Allergen specifische Immunotherapie: neue Ansätze. Praxis 2010; 99: 1279-84.